Sanofi to invest $474M annually on mRNA vaccine R&D

By The Science Advisory Board staff writers

June 30, 2021 -- Sanofi will spend approximately 400 million euros ($474 million U.S.) to accelerate the research and development (R&D) of messenger RNA (mRNA) vaccines.

The company will accelerate vaccine work through its newly launched vaccines mRNA Center of Excellence, which will consist of 400 employees from sites in Massachusetts and France working to deliver next-generation mRNA vaccines against unmet diseases.

The teams will focus on R&D, digital, and chemistry, manufacturing and controls (CMC) of mRNA vaccines in both locations. By 2025, Sanofi hopes to have six clinical vaccine candidates.

Millennium Technology Prize awarded to NGS pioneers
The Technology Academy Finland awarded the 2020 Millennium Technology Prize to Shankar Balasubramanian, PhD, and David Klenerman, PhD, chemists from Cambridge...
Sanofi, GSK COVID-19 vaccine to advance to phase III trials
Sanofi and GlaxoSmithKline's (GSK's) adjuvanted, recombinant COVID-19 vaccine candidate produced strong rates of neutralizing antibody responses in all...
Cellectis, Sanofi partner on UCART clinical trials
Sanofi has agreed to supply anti-CD52 monoclonal antibody alemtuzumab for use in a lymphodepleting regimen in Cellectis-sponsored universal chimeric antigen...
Sanofi, Stanford partner to study immunology
Sanofi has entered into a three-year research collaboration with the Stanford University School of Medicine to advance the understanding of immunology...
Sanofi to provide fill/finish services for Moderna COVID-19 vaccine
Moderna has inked a new agreement with Sanofi in order to scale up U.S. manufacturing capacity for its COVID-19 vaccine.

Copyright © 2021 scienceboard.net


Conferences
Interphex 2021
October 19-21
New York City, New York United States
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter